Cargando…
Rethinking clinical study data: why we should respect analysis results as data
The development and approval of new treatments generates large volumes of results, such as summaries of efficacy and safety. However, it is commonly overlooked that analyzing clinical study data also produces data in the form of results. For example, descriptive statistics and model predictions are...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649650/ https://www.ncbi.nlm.nih.gov/pubmed/36357430 http://dx.doi.org/10.1038/s41597-022-01789-2 |
_version_ | 1784827842779938816 |
---|---|
author | Barros, Joana M. Widmer, Lukas A. Baillie, Mark Wandel, Simon |
author_facet | Barros, Joana M. Widmer, Lukas A. Baillie, Mark Wandel, Simon |
author_sort | Barros, Joana M. |
collection | PubMed |
description | The development and approval of new treatments generates large volumes of results, such as summaries of efficacy and safety. However, it is commonly overlooked that analyzing clinical study data also produces data in the form of results. For example, descriptive statistics and model predictions are data. Although integrating and putting findings into context is a cornerstone of scientific work, analysis results are often neglected as a data source. Results end up stored as “data products” such as PDF documents that are not machine readable or amenable to future analyses. We propose a solution to “calculate once, use many times” by combining analysis results standards with a common data model. This analysis results data model re-frames the target of analyses from static representations of the results (e.g., tables and figures) to a data model with applications in various contexts, including knowledge discovery. Further, we provide a working proof of concept detailing how to approach standardization and construct a schema to store and query analysis results. |
format | Online Article Text |
id | pubmed-9649650 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96496502022-11-15 Rethinking clinical study data: why we should respect analysis results as data Barros, Joana M. Widmer, Lukas A. Baillie, Mark Wandel, Simon Sci Data Article The development and approval of new treatments generates large volumes of results, such as summaries of efficacy and safety. However, it is commonly overlooked that analyzing clinical study data also produces data in the form of results. For example, descriptive statistics and model predictions are data. Although integrating and putting findings into context is a cornerstone of scientific work, analysis results are often neglected as a data source. Results end up stored as “data products” such as PDF documents that are not machine readable or amenable to future analyses. We propose a solution to “calculate once, use many times” by combining analysis results standards with a common data model. This analysis results data model re-frames the target of analyses from static representations of the results (e.g., tables and figures) to a data model with applications in various contexts, including knowledge discovery. Further, we provide a working proof of concept detailing how to approach standardization and construct a schema to store and query analysis results. Nature Publishing Group UK 2022-11-10 /pmc/articles/PMC9649650/ /pubmed/36357430 http://dx.doi.org/10.1038/s41597-022-01789-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Barros, Joana M. Widmer, Lukas A. Baillie, Mark Wandel, Simon Rethinking clinical study data: why we should respect analysis results as data |
title | Rethinking clinical study data: why we should respect analysis results as data |
title_full | Rethinking clinical study data: why we should respect analysis results as data |
title_fullStr | Rethinking clinical study data: why we should respect analysis results as data |
title_full_unstemmed | Rethinking clinical study data: why we should respect analysis results as data |
title_short | Rethinking clinical study data: why we should respect analysis results as data |
title_sort | rethinking clinical study data: why we should respect analysis results as data |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649650/ https://www.ncbi.nlm.nih.gov/pubmed/36357430 http://dx.doi.org/10.1038/s41597-022-01789-2 |
work_keys_str_mv | AT barrosjoanam rethinkingclinicalstudydatawhyweshouldrespectanalysisresultsasdata AT widmerlukasa rethinkingclinicalstudydatawhyweshouldrespectanalysisresultsasdata AT bailliemark rethinkingclinicalstudydatawhyweshouldrespectanalysisresultsasdata AT wandelsimon rethinkingclinicalstudydatawhyweshouldrespectanalysisresultsasdata |